INTRODUCTION
Cystinuria and Hartnup disease are well recognized, inherited disorders of renal and intestinal amino acid transport. In cystinuria, a specific transport defect for cystine and the dibasic amino acids lysine, arginine, and ornithine has been documented in vivo (1) (2) (3) and in vitro (4) (5) (6) . Hartnup disease is characterized by impaired renal and intestinal absorption of tryptophan and a large group of other monoamino-, monocarboxylic Dr. Groth's present address is the University of Freiburg, Freiburg, Germany.
Received for publication 22 February 1972 and in revised form 29 March 1972. amino acids with neutral, aromatic, and heterocyclic side chains (7) . These transport abnormalities, and the autosomal recessive inheritance pattern of both disorders have led to the notion that cystinuria and Hartnup disease are caused by mutations of specific membrane carrier proteins which catalyze group-specific transport of amino acids in gut and kidney. The mutation responsible for cystinuria exhibits tissue as well as substrate specificity. Two groups of workers have shown that peripheral leukocytes from cystinuric patients transported cystine and dibasic amino acids in vitro as well as control leukocytes did (8, 9) . To date, such experiments have not been carried out in Hartnup disease, nor have other tissues been examined in either disorder.
Skin fibroblasts, propagated in tissue culture, have become a particularly useful tool for the study of the gene action in man, since they can be obtained without risk and grown in amounts which far exceed those available from other tissue biopsies. More than 35 inherited enzyme defects have been demonstrated in these cells, which have also proven to be uniquely valuable in studying other genetic phenomena in mammalian cells (10) . Although skin fibroblasts have been shown to transport amino acids actively in vitro (11), we are aware of no previous attempts to determine if specific, inherited disorders of amino acid transport are expressed in this tissue. In the present study, we have examined the processes by which normal skin fibroblasts transport dibasic amino acids, cystine, and tryptophan, and have compared transport of these compounds in normal cells with that in fibroblasts obtained from patients with cystinuria and Hartnup disease.
METHODS
Cell lines. Three healthy subjects served as control donors for skin biopsies from which diploid fibroblasts were grown 2130 The Journal of Clinical Investigation Volume 51 August 1972 in tissue culture and subsequently used to establish normal transport parameters for dibasic amino acids, cystine, and tryptophan (cell lines C82, C87, and C120). In addition to these control cell lines, individuals with various genetic diseases which, according to our present knowledge, are not related to defects of transport or metabolism of dibasic amino acids, cystine, or tryptophan were investigated (P1: methylmalonic aciduria; P68: hyperglycinemia; P90: thoracic asphyxiant dystrophy; P96: hyperglycinuria; P117: propionicacidemia.) Cell lines from cystinuric individuals originated from two female (Cy 23 and Cy 24) and one male (Cy 48) adults. Each of these individuals had formed numerous cystine calculi and excreted cystine, lysine, arginine, and ornithine in great excess. Using the classification of Rosenberg (12) , their genotypic designations were: Cy 23, I/III; Cy 24, I/I; and Cy 48, I/II. Transport of tryptophan was studied in control cells and in cell line H98, derived from an asymptomatic 10 month old girl who excreted great excesses of alanine, serine, threonine, leucine, isoleucine, valine, tryptophan, phenylalanine, and tyrosine in the urine. This urinary amino acid pattern was typical for homozygous Hartnup disease.
Preparation and incubation of cells. Transport studies in human-skin fibroblasts, propagated in tissue culture and harvested as reported by Mahoney and Rosenberg (11) , were performed only with nondividing cells at comparable degrees of confluence, conditions which were usually reached three days after serial passage. Cells were incubated at 37°C and pH 7.34 in a phosphate-buffered saline containing the following ion concentrations in mEq/liter: Na+= 156; K+ = 4.2; Ca2 = 1.8; Mg' = 1.6; Cl-= 145; PO4`= 29; S04' = 1.6. Sodium-free buffers were prepared by replacing sodium chloride with equimolar amounts of Tris-HC1 (trishydromethyl-aminomethane), choline chloride, or potassium chloride. If substrate or inhibitor concentrations greater than 5 mM were used, NaCl was reduced to keep the osmolality of the reaction mixture constant. Incubation duration varied from 1 to 90 min.
In a typical experiment 0.1 ml of cell suspension (1.5-2 X 10' cells) were added to 0.4 ml of prewarmed incubation medium in preweighed 3.5 ml polypropylene centrifuge tubes containing substrates, inhibitors, and radioactive compounds to yield the desired concentrations in the total volume of 0.5 ml. Radioactivity in the standard incubation assay varied between 0.1 ,uCi/ml at low substrate concentrations and 1 ,uCi/ml at high substrate concentrations. The tube was then stoppered and placed in a 37°C water bath. Thorough and simultaneously gentle mixing of cells and incubation medium was accomplished in a specially designed apparatus, in which the horizontally adjusted tube was moved back and forth along a circular arc at 30 rpm, permitting the cell suspension to move alternatively from one end of the tube to the other. Incubation was terminated by submerging the tube for 5 sec in an isopropyl alcohol-dry ice bath, during which interval the incubation mixture reached a temperature of 4°C. This was followed by centrifugation at 48,000 g at 4°C for 10 min in a Sorvall RC2B centrifuge (Ivan Sorvall, Inc., Norwalk, Conn.). After centrifugation the tubes were prepared for wet weight determination as described previously (13) . The cell pellets (usually 3-4 mg wet weight) were disrupted by sonicating for 10 sec at 70 w in 0.5 ml 5%o TCA (trichloracetic acid) with the microtip assembly of a Branson cell disruptor, Model W185D (Branson Instruments Co., Stamford, Conn.). Incubation medium was treated with equal volumes of 10% TCA. After removing precipitated components by centrifugation at 48,000 g for 5 min, portions of tissue supernatant and incubation medium were counted in a Packard Liquid Scintillation Spectrometer as described previously (14) . The protein content of sonicated tissue was assayed by the procedure of Lowry, Rosebrough, Farr, and Randall (15) .
Metabolism. The metabolic conversion of L-lysine-U-"C and L-tryptophan-3-'4C was investigated in tissue supernatant and incubation medium after extraction of TCA with ether (16) by a single dimension descending paper chromatography in a solvent of butanol: acetic acid: water (4: 1: 2) and by a single dimension high voltage electrophoresis (13) .
The fractional recovery of nonmetabolized radioactive substrate was determined as described previously (13 isolated intestinal cells (19) in several fibroblast cell lines. The fractional recovery of nonmetabolized substrate in tissue supernatant and medium was determined for both compounds at medium substrate concentrations of 0.1 mm after different incubation periods, and at various concentrations (0.02-10 mM) after 1 min incubation periods. Time dependent and concentration dependent fractional recovery of both radioactive substances in the incubation medium was found to be 1-2% less than the radiochemical purity of the parent amino acid. The fractional recovery of lysine-14C and tryptophan-1'C in the tissue supernatant with increasing duration of incubation is shown in Fig. 2A . The recovery of tryptophan remained virtually constant even after 90 min of incubation, whereas an increasing portion of intracellular lysine was metabolized after 30 min. After a 90 min incubation period, nearly 40% of the intracellular radioactivity was found in the form of metabolites of lysine. Fig. 2B shows the fractional recovery of lysine-1'C and tryptophan-"C over a 50-fold range of substrate concentrations. In all cell lines studied (C82, C87, and H98), tryptophan-"C was not catabolized appreciably over this entire range of substrate concentrations, whereas an increasing fraction of lysine-"C was metabolized at substrate concentrations less than 0.4 mm. Control (C82 and C87) and cystinuric (Cy 23 and Cy 24) cell lines metabolized lysine identically. Unless otherwise stated, no correction for metabolism was applied to the uptake data to be discussed subsequently.
Transport of dibasic amino acids and cystine (Fig. 3A and solid line in Fig. 3B ). Again repeated determinations in each of these "cystinuric" cell lines failed to change with duration in culture. The time course of cystine uptake by two of these cystinuric lines (Cy 23, C24) was also identical to that noted in control cells (Fig. 4) .
Initial rate kinetics. The relationship of initial uptake velocity to substrate concentration was investigated for lysine, arginine, and cystine. For each substrate this kinetic analysis revealed saturable transport processes conforming to Michaelis-Menten equations. The distribution ratios for lysine and arginine decreased rapidly in a linear fashion when the substrate concentration exceeded 20 mm (Fig. 5) , indicating a nonsaturable portion of the uptake process. According to the method of Akedo and Christensen (17) , apparent diffusion constants (KD) of 0.24 per min for lysine and 0.58 per min for arginine were calculated and subsequently used to correct total uptake velocities (v) to yield initial rates of mediated transport (Y). When the corrected initial rates of lysine and arginine transport were plotted against the initial substrate concentration (At) according to the linear transformation of the Michaelis-Menten equation described by Lineweaver and Burk (18) , two-limbed curves with a sharp break at an initial substrate concentration of about 1 mm were obtained for lysine (Fig. 6) as well as for arginine (Fig. 7A) , indicating at least two separate transport mechanisms with widely differing affinities for each of these substrates.
The system preferentially used for substrate accumulation at low substrate concentrations (0.02-1 mM) was arbitrarily called system 1 (high affinity system), whereas the system preferentially mediating translocation of solute at high concentrations (>1mM), was denoted system 2 (low affinity system). The apparent kinetic constants (Table I) for lysine and arginine are virtually identical for both transport systems.
The initial velocity of cystine uptake was studied over a range of substrate concentrations from 0.25 mm to
2134
U. Groth and L. E. Rosenberg "/Af Competitive inhibition. To characterize further the mediated transport systems for lysine, arginine, and cystine, studies of the mutual interaction between dibasic amino acids and cystine were carried out. The data in Fig. 9 describe studies of the initial rate of lysine uptake in the presence and absence of arginine, ornithine, and cystine. In examining the high affinity system (system 1) observed preferentially at low substrate concentration, arginine and ornithine were added at a concentration of 1 mm and cystine was present at 0.5 mM. Arginine and ornithine inhibited lysine uptake markedly and equally, yielding a regression line with an ordinate intercept identical to that observed in the absence of either inhibitor. These results indicate competitive inhibition. The apparent inhibition constant (Ks) for both arginine and ornithine (0.15 mM) was in good agreement with KA1 for lysine (Table I ). In contrast, cystine failed to inhibit lysine uptake throughout this range of substrate concentrations.
Comparable results were found when the low affinity system (system 2) for lysine uptake was examined. Arginine and ornithine, each added at concentrations of 20 mm, inhibited lysine uptake equally and competitively with Kt values very similar to that calculated for Kt2 for lysine. Because of its limited solubility, cystine could not be tested as an inhibitor of system 2 for lysine. Completely analogous results were obtained when arginine was used as substrate and lysine, ornithine and cystine were used as inhibitors (Fig. 7B ). Lysine and ornithine inhibited arginine uptake equally and competitively, with Ki values very close to that noted for Ktl for arginine. Again, cystine failed to alter arginine uptake.
Finally, cystine uptake was examined in the presence of lysine, arginine and ornithine (1 mM) . No inhibition of cystine uptake was produced by any of the dibasic amino acids.
The above data indicate that lysine, arginine, and ornithine share a common transport system in cultured human fibroblasts, whereas mediated cystine uptake is accomplished by a completely different transport site. Furthermore, the common Kt and K4 values obtained for lysine, arginine and ornithine demonstrate that these three dibasic amino acids have identical affinity for the shared process.
Effect of extracellular Na' and K+ on initial rates of uptake. The data shown in Fig. 10 The initial rate of cystine uptake was also shown to be a sodiun-independent but potassium-sensitive system. At a substrate concentration of 0.1 mm, substitution of choline for sodium led to no appreciable inhibition of uptake, whereas replacement of sodium by potassium reduced initial uptake of 56% of control values.
Effect of metabolic inhibitors on initial rates of lysine uptake. The influence of several metabolic inhibitors on initial rates of lysine uptake was studied at a low substrate concentration (0.1 mM) where uptake is mediated preferentially by system 1, and at a high substrate concentration (10 mM) where system 2 preferentially brings about solute translocation (Table II) . Sodium cyanide and p-chloromercuribenzoate inhibited uptake markedly at low and high substrate concentrations, while 2,4-dinitrophenol and ouabain produced only modest inhibitory effects. Each inhibitor except 2,4-dinitrophenol reduced uptake by system 1 more than by system 2. ease. In the following experiments we characterized tryptophan transport in fibroblasts from controls (C82 and C87) and from a child with documented Hartnup disease (H98). These results are summarized in Fig. 11 . The accumulation of tryptophan (0.1 mM) proceeded rapidly during the first 2 min to reach a plateau after 60 min of incubation and (Fig. 11A) remained constant up to 90 min. No differences in time dependent uptake were observed between control cell lines and the Hartnup (KD = 0.42) was calculated as described above and used for correction of initial uptake velocities (Fig. 1B) . Initial rates of transport conformed to Michaelis-Menten equations, and double reciprocal analysis (Fig. 1iC) revealed the presence of two transport systems (Fig. 1 C) . System 1 (high affinity system) had a Kt1 of 0.02 mm and a Vraxl of 2.0 mM/min. The kinetic parameters of system 2 (low affinity system) were: Kt2 = 12.5 mM; V.ax2 = 10 mM/min. No differences in initial rates of cell line. uptake were found between control cell lines and the Tryptophan uptake was saturable. A diffusion constant Hartnup cell line at substrate concentrations ranging from 0.03 to 1 mm. Tryptophan uptake in cell line H98
was not determined for substrate concentrations higher than 1 mm.
The initial rate of tryptophan uptake was sodium independent at low and high substrate concentrations. Replacement of sodium in the medium by potassium inhibited tryptophan transport at low but not at high substrate concentrations (Table III) . In contrast, transport of two other neutral amino acids, a-aminoisobutyric acid and glycine, was shown to be sodiumn-dependent at both low and high substrate concentrations (Table III) . Thus, the sodium independent nature of the transport processes for lysine, cystine, and tryptophan was shown not to be a technical artifact.
The effect of metabolic inhibitors on initial rate of tryptophan uptake is shown in Table IV T S, significance of difference between choline and potassium containing buffer. § Not significantly different from control (P > 0.1).
Amino Acid Transport in Cultured Human Fibroblasts and tryptophan. Our data relating metabolic conversion of lysine and tryptophan (Fig. 1) to the transport of these substances by intact fibroblasts provide a basis for the theoretical interpretation of the observed time curves of uptake. Equilibrium conditions were not achieved for lysine uptake even after 90 min of incubation (Fig. 3) . Instead, the total intracellular radioactivity increased approximately linearly after 45 min of incubation, indicating a "stationary state" with a constant net inflow of substrate. According to Curran and Schultz (20) , this condition can be described as a time independent state by the derivative expression
dt in which A'. denotes total radioactivity inside the cell. If the time curve for lysine uptake is corrected for that portion of lysine-14C metabolized by the cell at any given time (Fig. 3B) , the course of uptake after 45 min of incubation shows another time independent state which reflects the condition of equilibrium and may be described by the expression dAC 0
dt in which A. is the fraction of chemically unaltered lysine. The steady-state condition of a metabolizable substrate, assuming unit area and unit volume is given by Ji -viJr = 0 (4) in which Ji is the net flow, vi the stoichiotnetric coefficient of the substance in the reaction and Jr the rate of chemical reaction (20) . Applied to our data, this equation states that during the portion of the time curve when a stationary state has been achieved, the rate of consumption of lysine within the cell is exactly balanced by an inflow of lysine, so that its intracellular concentration remains constant. The validity of this interpretation is strengthened by the contrasting properties of the uptake curve for tryptophan (Fig. 11A) , which was shown not to be metabolized under our experimental conditions. In this instance, equilibrium conditions were reached after 50 min of incubation, satisfying equation 2.
Since "CO2 evolution from lysine or tryptophan was not measured in our experiments and since efflux of trace amounts of labeled metabolites into the incubation medium may have escaped our detection, our estimates of substrate conversion may be low. This discrepancy does not affect the validity of our interpretation of the time curves as long as all flows of matter not explicitly determined in our system are time independent themselves. Such conditions might be expected in our experiments since the system was left for a sufficiently long time without external constraint.
Estimates of the kinetic parameters of the saturable transport systems for dibasic amino acids, cystine and tryptophan were made after very brief exposure of cells to external amino acids, assuming that the intracellular concentration found after such short incubation intervals represented the initial rate of uptake. Lineweaver-Burk plots (18) of the initial rates of uptake, corrected for an uptake portion due to diffusion (17) , indicated two transport systems with widely differing affinities and capacities for each of the substrates investigated except cystine. The transition from one mode of uptake to the other occurred at substrate concentrations in the range of 1 mm, a concentration roughly one order of magnitude above physiological plasma amino acid values (21) . If we extrapolate from cultured human fibroblasts to human fibroblasts in vivo, these data suggest that translocation of these solutes at physiological plasma amino acid concentrations is preferentially brought about by the high affinity system (system 1). The biological significance of the low affinity systems remains unexplained. More than one transport system for a given amino acid (one acting at low, the other at high substrate concentrations) have been found in a variety of microorganism (22) (23) (24) and mammalian cells (13, (25) (26) (27) In agreement with previous observations using rat kidney (29) or human leukocytes (8), competitive inhibition studies at low substrate concentrations revealed that cystine uptake by diploid fibroblasts is not mediated by the common transport system shared by the dibasic amino acids. In rat kidney and in leukocytes, arginine had an affinity for this shared system about twice that estimated for lysine. Our data with fibroblasts, however, indicate that lysine, arginine, and ornithine have identical affinities, not only for transport system 1 (high affinity) but also for system 2 (low affinity). The affinity of lysine for system 1 in fibroblasts (Kt = 0.1 mM) is virtually identical with that observed in human leukocytes (Kt = 0.08 mM) (8) . Similar identity was found for the affinity constants of cystine transport in the gut (5) (Kt = 0.71 mM) and in fibroblasts (Kt = 0.74 mM).
In contrast, the Kt of lysine transport in human gut mucosa (5) for the transport system shared by dibasic amino acids and lysine is about 25 times higher than that in human leukocytes (8) and fibroblasts. All these observations support the notion that some properties of amino acid transport systems in man are tissue-specific while others may be identical in several tissues. More information about the properties of transport systems in different tissues is needed before we can begin to understand the role of differentiation in the regulation of transport processes.
The transport systems in human fibrobasts for dibasic amino acids, cystine, and tryptophan are not sodiumdependent, in conformance with observations in human leukocytes (8, 30) and in Ehrlich ascites cells (25, 31) . Since lysine transport in intestine has been shown to be sodium-dependent (32, 33) we may conclude, again, that the process of differentiation changes certain important properties of transport systems.
The inhibitory effect of high extracellular potassium concentrations on lysine, cystine, and tryptophan uptake by their high affinity systems (system 1) and the absence of this effect on their low affinity systems (system 2) (see Fig. 10 and Table II) is consistent with previous observations (34, 35) . If we assume that system 1 is mediated and energy-dependent, and that system 2 is mediated but energy-independent (see Table IV ) our findings are consistent with an inhibitory action of potassium on the energy link for system 1, but this represents only one of several possible interpretations.
Absence of transport defect in fibroblasts from patients with cystinuria and Hartnup disease. Diploid human fibroblasts grown in tissue culture are presumed to contain the complete genome. The failure to demonstrate transport defects for dibasic amino acids and cystine in "cystinuric" cell strains as well as for tryptophan in a cell line from a patient with Hartnup disease indicates that the gene loci mutant in these diseases are not expressed in cultured human fibroblasts under the conditions of our study. This observation has some important consequences for further attempts to investigate the biochemical nature of transport defects. Movement of solutes across biological membranes has long been described in phenomenologic terms, assuming the existence of hypothetical carrier proteins in the translocation process. In recent years, proteins have been isolated from microbial species which appear to be integral parts of the transport system (36) . Since such analyses depend on the availability of large amounts of pure membrane components, the ability to grow human cells in culture and to compare membrane structure with transport functions in normal vs mutant cells would appear to be uniquely advantageous. It 
